Study identifier:D7412R00001
ClinicalTrials.gov identifier:NCT06448715
EudraCT identifier:N/A
CTIS identifier:N/A
Real-World Treatment Study of Soliris (Eculizumab)
observational
N/A
No
-
All
11
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|